P. Heinmöller

HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin.

J. Rüschoff, M. Pedrocchi, C. Schmidtgen, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

J. Rüschoff, W. Scaringe, W. Dietmaier, 2000, The American journal of pathology.

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

T. Henkel, J. Rüschoff, M. Kaufmann, 2007, Journal of Clinical Pathology.

Quality Control of Immunohistochemical and In Situ Hybridization Predictive Biomarkers for Patient Treatment: Experience from International Guidelines and International Quality Control Schemes

B. Jasani, Marius Grzelinski, G. Bänfer, 2018, Predictive Biomarkers in Oncology.